203 related articles for article (PubMed ID: 7915330)
1. Presymptomatic diagnosis in families with adenomatous polyposis using highly polymorphic dinucleotide CA repeat markers flanking the APC gene.
Eckert WA; Jung C; Wolff G
J Med Genet; 1994 Jun; 31(6):442-7. PubMed ID: 7915330
[TBL] [Abstract][Full Text] [Related]
2. Presymptomatic diagnosis of familial adenomatous polyposis coli.
Park JG; Han HJ; Kang MS; Nakamura Y
Dis Colon Rectum; 1994 Jul; 37(7):700-7. PubMed ID: 7913010
[TBL] [Abstract][Full Text] [Related]
3. Presymptomatic diagnosis of familial colon polyposis.
Tóth T; Kristóf T; Ujszászy L; Gerö G; Nagy B; Papp Z
Acta Biol Hung; 1997; 48(3):377-83. PubMed ID: 9406616
[TBL] [Abstract][Full Text] [Related]
4. A CA-repeat polymorphism close to the adenomatous polyposis coli (APC) gene offers improved diagnostic testing for familial APC.
Spirio L; Nelson L; Ward K; Burt R; White R; Leppert M
Am J Hum Genet; 1993 Feb; 52(2):286-96. PubMed ID: 8094265
[TBL] [Abstract][Full Text] [Related]
5. Presymptomatic diagnosis of familial adenomatous polyposis using intragenic polymorphisms and CA repeats flanking the APC gene.
Hayes VM; Kotze MJ; Grobbelaar JJ; Madden MV; Ramesar R; Oosthuizen CJ
Genet Couns; 1996; 7(1):1-7. PubMed ID: 8652082
[TBL] [Abstract][Full Text] [Related]
6. Molecular screening of families affected by familial adenomatous polyposis (FAP).
Gazzoli I; De Andreis C; Sirchia SM; Sala P; Rossetti C; Bertario L; Colucci G
J Med Screen; 1996; 3(4):195-9. PubMed ID: 9041484
[TBL] [Abstract][Full Text] [Related]
7. The use of DNA markers in the pre-clinical diagnosis of familial adenomatous polyposis.
Amikam D; Niv D; Lachter J; Eidelman S; Ben-Ishai Z
Isr J Med Sci; 1997 Jan; 33(1):8-13. PubMed ID: 9203511
[TBL] [Abstract][Full Text] [Related]
8. Presymptomatic diagnosis in Portuguese FAP families using intragenic RFLPs and (CA)n flanking markers by fluorescence based semiautomated DNA analysis.
Almeida R; Fidalgo P; Ramalho E; Brás A; Leitão N; Mira C; Rueff J; Monteiro C
J Med Genet; 1996 Mar; 33(3):244-7. PubMed ID: 8728702
[TBL] [Abstract][Full Text] [Related]
9. Improved predictive carrier testing for familial adenomatous polyposis using DNA from a single archival specimen and polymorphic markers with multiple alleles.
Bapat B; Mitri A; Greenberg CR
Hum Pathol; 1993 Dec; 24(12):1376-9. PubMed ID: 8276387
[TBL] [Abstract][Full Text] [Related]
10. Presymptomatic diagnosis of familial adenomatous polyposis by bridging DNA markers.
Tops CM; Wijnen JT; Griffioen G; von Leeuwen IS; Vasen HF; den Hartog Jager FC; Breukel C; Nagengast FM; van der Klift HM; Lamers CB
Lancet; 1989 Dec; 2(8676):1361-3. PubMed ID: 2574305
[TBL] [Abstract][Full Text] [Related]
11. CA repeat polymorphism at the D5S299 locus linked to adenomatous polyposis coli (APC).
van Leeuwen C; Tops C; Breukel C; van der Klift H; Fodde R; Khan PM
Nucleic Acids Res; 1991 Oct; 19(20):5805. PubMed ID: 1658745
[No Abstract] [Full Text] [Related]
12. Genetic linkage map of six polymorphic DNA markers around the gene for familial adenomatous polyposis on chromosome 5.
Dunlop MG; Wyllie AH; Nakamura Y; Steel CM; Evans HJ; White RL; Bird CC
Am J Hum Genet; 1990 Dec; 47(6):982-7. PubMed ID: 1978564
[TBL] [Abstract][Full Text] [Related]
13. Familial papillary thyroid carcinoma is genetically distinct from familial adenomatous polyposis coli.
Malchoff CD; Sarfarazi M; Tendler B; Forouhar F; Whalen G; Malchoff DM
Thyroid; 1999 Mar; 9(3):247-52. PubMed ID: 10211600
[TBL] [Abstract][Full Text] [Related]
14. Ophthalmic and genetic screening in pedigrees with familial adenomatous polyposis.
Ruhswurm I; Zehetmayer M; Dejaco C; Wolf B; Karner-Hanusch J
Am J Ophthalmol; 1998 May; 125(5):680-6. PubMed ID: 9625552
[TBL] [Abstract][Full Text] [Related]
15. Pigmented ocular fundus lesions and APC mutations in familial adenomatous polyposis.
Traboulsi EI; Apostolides J; Giardiello FM; Krush AJ; Booker SV; Hamilton SR; Hussels IE
Ophthalmic Genet; 1996 Dec; 17(4):167-74. PubMed ID: 9010867
[TBL] [Abstract][Full Text] [Related]
16. Combined use of molecular and biomarkers for presymptomatic carrier risk assessment in familial adenomatous polyposis: implications for screening guidelines.
Bapat BV; Parker JA; Berk T; Cohen Z; McLeod RS; Ray PN; Stern HS
Dis Colon Rectum; 1994 Feb; 37(2):165-71. PubMed ID: 7905818
[TBL] [Abstract][Full Text] [Related]
17. Congenital hypertrophy of the retinal pigment epithelium in familial adenomatous polyposis. Novel criteria of assessment and correlations with constitutional adenomatous polyposis coli gene mutations.
Valanzano R; Cama A; Volpe R; Curia MC; Mencucci R; Palmirotta R; Battista P; Ficari F; Mariani-Costantini R; Tonelli F
Cancer; 1996 Dec; 78(11):2400-10. PubMed ID: 8941012
[TBL] [Abstract][Full Text] [Related]
18. Screening by genomic linkage studies and mutation analysis of hereditary adenomatous polyposis coli: usefulness for clinical practice.
Karner-Hanusch J; Wolf B; Zehetmayer M; Wrba F; Roth E; Mannhalter C
World J Surg; 1996 Jun; 20(5):578-83; discussion 583-4. PubMed ID: 8661634
[TBL] [Abstract][Full Text] [Related]
19. Predictive diagnosis of familial adenomatous polyposis with linked DNA markers: population based study.
MacDonald F; Morton DG; Rindl PM; Haydon J; Cullen R; Gibson J; Neoptolemos JP; Keighley MR; McKeown CM; Hultén M
BMJ; 1992 Apr; 304(6831):869-72. PubMed ID: 1327364
[TBL] [Abstract][Full Text] [Related]
20. Predictive diagnosis in familial adenomatous polyposis: evaluation of molecular genetic and ophthalmologic methods.
Caspari R; Friedl W; Böker T; Augustin A; Mandl M; Jaeger K; Gallkowski K; Propping P
Z Gastroenterol; 1993 Nov; 31(11):646-52. PubMed ID: 8291275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
